Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
Clinical trial NCT01644188 · COMPLETED
Trial details
- NCT number
- NCT01644188
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-05-01
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.